Clinical Trials
36 trialsStudy of Kidney Tumors in Younger Patients
Children's Oncology Group
INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Trakya University
GFANEPHRO20
French Africa Pediatric Oncology Group
BRICCS
Mayo Clinic
VIN
Assistance Publique - HĂ´pitaux de Paris
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
RenJi Hospital
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
International PPB/DICER1 Registry
Children's Hospitals and Clinics of Minnesota
PsyRareCare
Universitätsklinikum Hamburg-Eppendorf
Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Study of Wilms Tumors Among Patients of Shefa Al-Orman Children Cancer Hospital
South Egypt Cancer Institute
PPB
Children's National Research Institute
Drug Sensitivity and Mutation Profiling
Florida International University
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
West China Hospital
Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
M.D. Anderson Cancer Center
Collaborative Wilms Tumour Africa Project
Amsterdam UMC, location VUmc
Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
National Institutes of Health Clinical Center (CC)
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Vanderbilt-Ingram Cancer Center
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
Children's Oncology Group
Gene Analysis in Studying Susceptibility to Wilms Tumor
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Biomarkers in Urine Samples From Patients With Wilms Tumor
Children's Oncology Group
DNA Variations in the Gene in Young Patients With Wilms' Tumor
Children's Oncology Group
Gene Expression Profiles to Categorize Wilms Tumors
Children's Oncology Group
Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor
Children's Oncology Group
Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
Children's Oncology Group
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
LAM-MMR
A.O.U. CittĂ della Salute e della Scienza
Registry for Patients With Wilms' Tumor Suppressor Gene 1 (WT1) Mutation Associated Diseases
Universitätsklinikum Hamburg-Eppendorf
Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors
Children's Oncology Group
Studying Biomarkers in Urine Samples From Younger Patients With Wilms Tumor
Children's Oncology Group
iCAT for Recurrent/Refractory/HR Solid Tumors
Dana-Farber Cancer Institute
Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant
Mayo Clinic
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center